Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping
暂无分享,去创建一个
Nian Wang | Xiaojun Xu | Minming Zhang | Min Xuan | Chunlei Liu | Peiyu Huang | Chunlei Liu | Xiaojun Xu | Xiao-jun Guan | Min Xuan | Quanquan Gu | P. Huang | Minming Zhang | W. Luo | Nian Wang | Quanquan Gu | Wei Luo | Xiaojun Guan | Xiaojun Guan | Peiyu Huang
[1] P. Yu,et al. Brain iron accumulation exacerbates the pathogenesis of MPTP-induced Parkinson’s disease , 2015, Neuroscience.
[2] P Z Marmarelis,et al. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. , 1999, Magnetic resonance imaging.
[3] Xuemei Huang,et al. Higher iron in the red nucleus marks Parkinson's dyskinesia , 2013, Neurobiology of Aging.
[4] Chunlei Liu,et al. Whole brain susceptibility mapping using compressed sensing , 2012, Magnetic resonance in medicine.
[5] Marguerite Wieler,et al. Midbrain iron content in early Parkinson disease , 2008, Neurology.
[6] P D Griffiths,et al. Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease. , 1993, Dementia.
[7] Ferdinand Schweser,et al. Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study , 2012, NeuroImage.
[8] A. Lees,et al. Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.
[9] F. Ye,et al. Basal ganglia iron content in Parkinson's disease measured with magnetic resonance , 1996, Movement disorders : official journal of the Movement Disorder Society.
[10] P D Griffiths,et al. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. , 2000, Brain : a journal of neurology.
[11] M. I. Argyropoulou,et al. MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease , 2005, Journal of Neurology.
[12] D. Dexter,et al. Neurodegenerative diseases and therapeutic strategies using iron chelators. , 2015, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[13] Ke Xu,et al. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients. , 2013, Magnetic resonance imaging.
[14] D. Mash,et al. Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated mice , 1991, Experimental Neurology.
[15] Martin Styner,et al. Imaging nigral pathology and clinical progression in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[16] A. Graybiel,et al. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.
[17] T. Liimatainen,et al. T1ρ and T2ρ MRI in the evaluation of Parkinson’s disease , 2010, Journal of Neurology.
[18] I. Elovaara,et al. Clinical MRI for iron detection in Parkinson's disease. , 2013, Clinical imaging.
[19] C D Marsden,et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.
[20] Chunlei Liu,et al. Association between increased magnetic susceptibility of deep gray matter nuclei and decreased motor function in healthy adults , 2015, NeuroImage.
[21] J. Connor,et al. Iron in the brain. , 2009, Nutrition reviews.
[22] Nan Luo,et al. Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times , 2010, Movement disorders : official journal of the Movement Disorder Society.
[23] P Riederer,et al. Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains , 1991, Journal of neurochemistry.
[24] Xuemei Huang,et al. Quantitative susceptibility mapping of the midbrain in Parkinson's disease , 2016, Movement disorders : official journal of the Movement Disorder Society.
[25] Wei Cao,et al. A method for estimating and removing streaking artifacts in quantitative susceptibility mapping , 2015, NeuroImage.
[26] P D Griffiths,et al. Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. , 1999, Brain : a journal of neurology.
[27] K. Jellinger,et al. Brain iron and ferritin in Parkinson's and Alzheimer's diseases , 1990, Journal of neural transmission. Parkinson's disease and dementia section.
[28] W. Geldenhuys,et al. Brain Iron Toxicity: Differential Responses of Astrocytes, Neurons, and Endothelial Cells , 2007, Neurochemical Research.
[29] Christian Langkammer,et al. Differential developmental trajectories of magnetic susceptibility in human brain gray and white matter over the lifespan , 2014, Human brain mapping.
[30] Bing Wu,et al. Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition , 2011, NeuroImage.
[31] Chiou-Lian Lai,et al. PARKINSON’S DISEASE PATIENTS , 2008 .
[32] J. Obeso,et al. Pathophysiology of the basal ganglia in Parkinson's disease , 2000, Trends in Neurosciences.
[33] John Hardy,et al. Parkinson's disease , 2009, The Lancet.
[34] Xue Xiao,et al. Integrated Laplacian‐based phase unwrapping and background phase removal for quantitative susceptibility mapping , 2014, NMR in biomedicine.
[35] Wei Li,et al. Susceptibility‐weighted imaging and quantitative susceptibility mapping in the brain , 2015, Journal of magnetic resonance imaging : JMRI.
[36] Kemin Chen,et al. Region‐specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping , 2015, Human brain mapping.
[37] Stephen R Lord,et al. Clinical and physiological assessments for elucidating falls risk in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.
[38] Tian Liu,et al. Internal structures of the globus pallidus in patients with Parkinson’s disease: evaluation with quantitative susceptibility mapping (QSM) , 2015, European Radiology.
[39] Torsten Rohlfing,et al. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping , 2011, NeuroImage.